Pyridazinone derivatives, through their ability to target PDE4, exert many potential activities [12,13] such as anti-inflammatory, anti-viral, anti-microbial and anti-obesity as well as anti-cancer activity [14,15,16,17]. This evidence concerns the gene PDE4A and cancer.